10 results
P
people being investigated for tuberculosis
I/C
Xpert MTB/RIF, smear microscopy
O
mortality, proportion of participants starting tuberculosis treatment who had a successful treatment outcome, proportion of participants who were treated for tuberculosis, proportion of participants with bacteriological confirmation who were lost to follow-up pre-treatment, proportion of treated participants who had bacteriological confirmation
P
Irritable Bowel Syndrome
I/C
Acupuncture, Moxibustion, No Intervention
O
Abdominal Pain, Altered Bowel Habits
P
patients with dry eye
I/C
autologous serum treatment, artificial tear drops
O
adverse effects, quality of life, severity of the pathology, pain, corneal epitheliopathy grade
P
COVID-19 patients
I/C
3-drugs-3-formulas, conventional treatment
O
duration of fever, cough, fatigue, length of hospital stay, time for nucleic acid conversion, aggravation rate, mortality, recovery rate of chest computerized tomography manifestations, total effectiveness
P
Patients with dyslipidemia
I/C
High-dose atorvastatin (80 mg), Other therapies
O
Reduced risk of Major Cardiovascular Events (MACE), mortality, and adverse events
P
adult population of Peru
I/C
systematic review and meta-analysis of epidemiological studies, random sampling approach in adult population
O
prevalence and incidence of arterial hypertension, previous diagnosis of arterial hypertension
P
pacientes con COVID-19
I/C
inhibidores de la enzima convertidora de angiotensina, bloqueadores del receptor de angiotensina II, placebo o ningún tratamiento
O
efectos sobre la COVID-19